DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Food, Beverage & Tobacco
Updated 36m ago
TATE logo

Tate & Lyle plcLSE:TATE Stock Report

Market Cap UK£2.5b
Updated 36m ago
Share Price
n/a
1Y8.3%
7D0%
1D0.2%
Portfolio Value
​
View

Tate & Lyle plc

LSE:TATE Stock Report

Market Cap: UK£2.5b

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Tate & Lyle (TATE) Stock Overview

Engages in the provision of ingredients and solutions to the food, beverages, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. More details

TATE fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance4/6
Financial Health2/6
Dividends2/6

Rewards

Trading at 68% below our estimate of its fair value

Earnings are forecast to grow 18.18% per year

Earnings grew by 102.1% over the past year

Risk Analysis

Debt is not well covered by operating cash flow

Dividend of 3.55% is not well covered by earnings

Large one-off items impacting financial results


TATE Community Fair Values

Create Narrative

See what 56 others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
4.3% overvalued intrinsic discount
AnalystConsensusTarget
•1mo ago

TATE: Revenue Guidance Revisions Will Drive Near-Term Re-Rating Opportunity

364
0
35
AN
AnalystLowTarget
34.9% overvalued intrinsic discount
AnalystLowTarget
•1mo ago

Regulatory And Integration Hurdles Will Constrain Upside But Spur Revaluation

126
0
5
AN
AnalystHighTarget
9.3% undervalued intrinsic discount
AnalystHighTarget
•2mo ago

Rising Health Trends And Urbanization Will Expand Specialty Markets

29
0
0

Top Analyst Narratives

AN
AnalystConsensusTarget
4.3% overvalued intrinsic discount
AnalystConsensusTarget
•1mo ago

TATE: Revenue Guidance Revisions Will Drive Near-Term Re-Rating Opportunity

364
0
35
AN
AnalystLowTarget
34.9% overvalued intrinsic discount
AnalystLowTarget
•1mo ago

Regulatory And Integration Hurdles Will Constrain Upside But Spur Revaluation

126
0
5
AN
AnalystHighTarget
9.3% undervalued intrinsic discount
AnalystHighTarget
•2mo ago

Rising Health Trends And Urbanization Will Expand Specialty Markets

29
0
0
View all narratives

Tate & Lyle plc Competitors

Cranswick

Symbol: LSE:CWK
Market cap: UK£2.7b

Premier Foods

Symbol: LSE:PFD
Market cap: UK£1.6b

Princes Group

Symbol: LSE:PRN
Market cap: UK£728.0m

Hilton Food Group

Symbol: LSE:HFG
Market cap: UK£600.5m

Price History & Performance

Summary of share price highs, lows and changes for Tate & Lyle
Historical stock prices
Current Share PriceUK£5.58
52 Week HighUK£5.80
52 Week LowUK£3.19
Beta0.35
1 Month Change0.81%
3 Month Change-1.24%
1 Year Change8.35%
3 Year Change-21.41%
5 Year Change-28.91%
Change since IPO19.57%

Recent News & Updates

User avatar
Narrative Update • Jul 30

TATE: Future Share Price Will Reflect Risks Around Ingredion Takeover Proposal

Analysts have modestly raised their fair value estimate for Tate & Lyle, with the implied price target moving from about £3.75 to roughly £4.14. This reflects updated assumptions on revenue growth, profit margin and future P/E, even as recent research has shifted ratings toward Hold.
User avatar
Narrative Update • Jul 15

TATE: Ingredion Offer And Margin Delivery Will Shape Balanced Future Returns

Tate & Lyle’s updated analyst work points to a modestly higher fair value estimate, with the aggregate price target now effectively aligned around the mid £5 range. Analysts reflect a slightly higher discount rate, a small adjustment to revenue and margin assumptions, and a higher future P/E, set against recent downgrades to Hold ratings linked to the Ingredion offer.
User avatar
Narrative Update • Jul 01

TATE: Ingredion Offer And Margin Outlook Will Shape Balanced Future Return Potential

Analysts have trimmed their fair value estimate for Tate & Lyle from £6.67 to £6.15. Recent downgrades to Hold and reduced price targets reflect a more cautious stance following the firm offer from Ingredion, slightly higher discount rate assumptions and a lower future P/E multiple, partly offset by modestly improved profit margin expectations.
User avatar
Narrative Update • Jun 17

TATE: Future Share Price Will Reflect Execution Risks Under Takeover Proposal

The analyst price target for Tate & Lyle has been revised to £5.47. This reflects updated views on softer revenue growth assumptions, a slightly higher profit margin outlook and recent changes in Street research ratings and targets.

Recent updates

User avatar
Narrative Update • Jul 30

TATE: Future Share Price Will Reflect Risks Around Ingredion Takeover Proposal

Analysts have modestly raised their fair value estimate for Tate & Lyle, with the implied price target moving from about £3.75 to roughly £4.14. This reflects updated assumptions on revenue growth, profit margin and future P/E, even as recent research has shifted ratings toward Hold.
User avatar
Narrative Update • Jul 15

TATE: Ingredion Offer And Margin Delivery Will Shape Balanced Future Returns

Tate & Lyle’s updated analyst work points to a modestly higher fair value estimate, with the aggregate price target now effectively aligned around the mid £5 range. Analysts reflect a slightly higher discount rate, a small adjustment to revenue and margin assumptions, and a higher future P/E, set against recent downgrades to Hold ratings linked to the Ingredion offer.
User avatar
Narrative Update • Jul 01

TATE: Ingredion Offer And Margin Outlook Will Shape Balanced Future Return Potential

Analysts have trimmed their fair value estimate for Tate & Lyle from £6.67 to £6.15. Recent downgrades to Hold and reduced price targets reflect a more cautious stance following the firm offer from Ingredion, slightly higher discount rate assumptions and a lower future P/E multiple, partly offset by modestly improved profit margin expectations.
User avatar
Narrative Update • Jun 17

TATE: Future Share Price Will Reflect Execution Risks Under Takeover Proposal

The analyst price target for Tate & Lyle has been revised to £5.47. This reflects updated views on softer revenue growth assumptions, a slightly higher profit margin outlook and recent changes in Street research ratings and targets.
User avatar
Narrative Update • Jun 02

TATE: Future Earnings Profile Will Reflect Cautious Margins Under Takeover Overhang

Analysts have trimmed the price target on Tate & Lyle by £0.15 to £5.47, citing updated assumptions for revenue growth, profit margins and future P/E, along with a recent shift in ratings from Buy to Hold. Analyst Commentary Bearish analysts have shifted to a more cautious stance on Tate & Lyle, pairing a downgrade in rating with lower price targets clustered around £5.47.
User avatar
Narrative Update • May 13

TATE: Future Earnings Profile Will Reflect Cautious Assumptions And Raised Execution Hurdle

Analysts have trimmed their average price target for Tate & Lyle to about £3.75 from roughly £3.85, reflecting recent target cuts of around £0.15 to £0.24 per share and updated views on growth, profitability and appropriate P/E multiples. Analyst Commentary Recent research updates have leaned cautious, with several bearish analysts cutting price targets and reassessing how much they are willing to pay for Tate & Lyle shares.
User avatar
Narrative Update • Apr 28

TATE: Higher Future P/E Assumptions Will Support Bullish Case For Upside

Analysts have trimmed their consolidated price target for Tate & Lyle by around £0.05 per share, reflecting refreshed assumptions around slightly higher revenue growth, lower profit margins, and a higher future P/E multiple. Analyst Commentary Recent Street research summarises a series of price target trims around Tate & Lyle, paired with updated assumptions on growth, margins, and valuation multiples.
User avatar
Narrative Update • Apr 14

TATE: Reset Price Expectations Will Support Future Upside If Margins Hold

The analyst price target for Tate & Lyle has been reduced by approximately £0.17 per share, as analysts incorporate slightly lower fair value estimates, a modestly higher discount rate, and more conservative assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research shows a series of reductions to Tate & Lyle price targets in £0.15 to £0.24 per share increments, with at least one target now set at £5.00 from £5.40.
User avatar
Narrative Update • Mar 31

TATE: Future Earnings Profile Will Reflect Cautious Assumptions And Limited Upside Potential

Analysts have trimmed their price target on Tate & Lyle to £5.00 from £5.40, citing updated assumptions on the discount rate, revenue growth, profit margin and future P/E multiples. Analyst Commentary The cut in the price target to £5.00 from £5.40 signals that some expectations around Tate & Lyle's future performance and valuation have been reined in.
User avatar
Narrative Update • Mar 17

TATE: Future Earnings Profile Will Reflect Cautious Outlook And Higher Required Returns

Analysts have reduced their fair value estimate for Tate & Lyle, bringing it into line with a lower Street price target. Citi has cut its target from £5.40 to £5.00, reflecting updated assumptions on growth, margins and the P/E multiple.
User avatar
Narrative Update • Mar 03

TATE: Reduced Fair Value Will Support Bullish Case For Future Upside

The analyst price target for Tate & Lyle has been reduced by £0.40 to £5.00, as analysts incorporate updated assumptions on growth, profitability and valuation multiples while still seeing potential upside in the shares. Analyst Commentary Bullish analysts have trimmed their price targets slightly, with the latest move taking the target to £5.00 from £5.40, but they continue to see room for upside from current levels.
User avatar
Narrative Update • Feb 16

TATE: Stable Cash Margins And P/E Repricing Will Support Future Upside

Analysts have adjusted their price target on Tate & Lyle to £5.01, with the change reflecting updated assumptions for the discount rate and future P/E multiple, while keeping revenue growth and profit margin expectations broadly in line with prior estimates. Valuation Changes Fair Value: Estimated fair value remains effectively unchanged at £5.01 per share.
Analysis Article • Feb 05

Getting In Cheap On Tate & Lyle plc (LON:TATE) Is Unlikely

It's not a stretch to say that Tate & Lyle plc's ( LON:TATE ) price-to-sales (or "P/S") ratio of 0.9x right now seems...
User avatar
Narrative Update • Feb 02

TATE: Future Earnings Profile Will Reflect Higher Dividend And Softer Revenue Outlook

Analysts have trimmed their price target on Tate & Lyle slightly to £3.99, reflecting modest adjustments to revenue growth and discount rate assumptions, alongside a small uplift in expected profit margins and a slightly lower future P/E. What's in the News The Board approved an interim dividend of 6.6 pence per share for the six months to 30 September 2025, with payment scheduled for 5 January 2026 to shareholders on the register as of 21 November 2025 (company announcement).
User avatar
Narrative Update • Jan 19

TATE: Higher Interim Dividend Will Support Renewed Shareholder Value Potential

Analysts have slightly trimmed their fair value estimate for Tate & Lyle to £5.01 from about £5.03, reflecting updated assumptions that combine a modestly lower revenue growth outlook with a higher expected profit margin and a reduced future P/E multiple. What's in the News Tate & Lyle approved an interim dividend for the six months to 30 September 2025 of 6.6 pence per share.
User avatar
Narrative Update • Jan 05

TATE: Future Earnings Profile Will Reflect Dividend Increase And Soft Revenue Outlook

Analysts have slightly reduced their price target on Tate & Lyle to reflect a broadly unchanged fair value of approximately £3.99, despite modest upgrades to revenue growth and profit margin assumptions and a lower future P/E multiple. What's in the News Board approves a higher interim dividend of 6.6 pence per share for the six months to 30 September 2025, up from 6.4 pence in 2024, payable on 5 January 2026 to shareholders on the register as of 21 November 2025 (Key Developments) Company maintains full year guidance for the year ending 31 March 2026, expecting revenue to decline by a low single digit percentage compared with the prior year (Key Developments) Valuation Changes Fair Value: edged down slightly from £4.00 to £3.99 per share, implying a negligible change in estimated intrinsic value.
User avatar
Narrative Update • Dec 15

TATE: Guidance And Contract Pressures Are Expected To Reshape Future Earnings Profile

Our updated narrative on Tate & Lyle reflects a reduced fair value estimate and lower price target, moving from the high 600s GBp toward the 430 to 540 GBp range, as analysts factor in more cautious fiscal 2026 guidance, softer contract renewals, and increased risk to medium term targets from sucralose exposure. Analyst Commentary Bearish analysts have turned more cautious on Tate & Lyle, cutting ratings and trimming price targets in response to updated guidance and rising execution risk.
User avatar
Narrative Update • Nov 29

TATE: Interim Dividend Hike And Market Recovery Will Drive Renewed Shareholder Value

Tate & Lyle's analyst price target has been reduced substantially, with new targets ranging from 430 GBp to 540 GBp. Analysts cite concerns around conservative fiscal guidance and potential contract headwinds as factors weighing on future growth estimates. Analyst Commentary Recent analyst coverage of Tate & Lyle reflects a mix of optimism around the company's long-term prospects and concerns about near-term pressures impacting valuation and growth forecasts.
User avatar
Narrative Update • Nov 15

TATE: Near-Term Headwinds Will Present Attractive Recovery Opportunity Ahead

Tate & Lyle's consensus price target has been reduced significantly, with analysts citing cautious fiscal guidance and industry contract headwinds as key factors in the revised outlook. The price target has shifted from approximately £6.50 down to a range between £4.30 and £5.40 per share.
Analysis Article • Nov 09

Tate & Lyle (LON:TATE) Has Announced A Dividend Of £0.066

Tate & Lyle plc's ( LON:TATE ) investors are due to receive a payment of £0.066 per share on 5th of January. This makes...
User avatar
Narrative Update • Oct 31

TATE: Revenue Guidance Revisions Will Drive Near-Term Re-Rating Opportunity

Tate & Lyle's analyst price target has been reduced from approximately £5.53 to £5.28 per share, as analysts cite concerns over the company's revised guidance and increased risks to its medium-term outlook. Analyst Commentary Recent research notes show a range of perspectives regarding Tate & Lyle's performance and future prospects, highlighting both potential strengths and emerging risks for the company.
User avatar
Narrative Update • Oct 17

Integrating CP Kelco And Partnering With Manus Will Drive Growth And Enhance Profitability

Tate & Lyle's analyst price target has been revised downward by approximately 12%, from £6.26 to £5.53 per share. Analysts cite growing concerns over softer demand trends and pressure on future earnings growth.
User avatar
Narrative Update • Oct 03

Integrating CP Kelco And Partnering With Manus Will Drive Growth And Enhance Profitability

Tate & Lyle’s analyst price target has been revised downward by analysts, dropping sharply from approximately £7.09 to £6.26 per share. Recent research highlights concerns about a softer revenue growth outlook and potential headwinds from contract renegotiations and product mix changes.
Analysis Article • Oct 02

Why We're Not Concerned Yet About Tate & Lyle plc's (LON:TATE) 26% Share Price Plunge

The Tate & Lyle plc ( LON:TATE ) share price has fared very poorly over the last month, falling by a substantial 26...
User avatar
Narrative Update • Sep 17

Integrating CP Kelco And Partnering With Manus Will Drive Growth And Enhance Profitability

The slight reduction in Tate & Lyle’s consensus price target reflects a modest decline in net profit margin, resulting in a new fair value of £7.09. What's in the News Tate & Lyle is showcasing health-focused ingredient innovations at the IFT FIRST Conference, including advancements in sugar reduction, fiber fortification, and novel textures.
Analysis Article • Jul 04

Market Participants Recognise Tate & Lyle plc's (LON:TATE) Earnings

When close to half the companies in the United Kingdom have price-to-earnings ratios (or "P/E's") below 16x, you may...
Analysis Article • Mar 11

Tate & Lyle (LON:TATE) Seems To Use Debt Quite Sensibly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Feb 13

Potential Upside For Tate & Lyle plc (LON:TATE) Not Without Risk

With a median price-to-earnings (or "P/E") ratio of close to 16x in the United Kingdom, you could be forgiven for...
User avatar
New Narrative • Dec 17

Integrating CP Kelco And Partnering With Manus Will Drive Growth And Enhance Profitability

Expansion through CP Kelco enhances specialty solutions, driving revenue growth and improving profitability via anticipated cost synergies and EBITDA margin uplift.
Analysis Article • Nov 19

Analysts Just Published A Bright New Outlook For Tate & Lyle plc's (LON:TATE)

Tate & Lyle plc ( LON:TATE ) shareholders will have a reason to smile today, with the analysts making substantial...
Analysis Article • Nov 12

Tate & Lyle (LON:TATE) Will Pay A Dividend Of £0.064

The board of Tate & Lyle plc ( LON:TATE ) has announced that it will pay a dividend of £0.064 per share on the 6th of...
Analysis Article • Nov 07

Tate & Lyle plc's (LON:TATE) Shareholders Might Be Looking For Exit

There wouldn't be many who think Tate & Lyle plc's ( LON:TATE ) price-to-earnings (or "P/E") ratio of 16.2x is worth a...
Analysis Article • Oct 10

Here's Why We Think Tate & Lyle (LON:TATE) Is Well Worth Watching

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Analysis Article • Sep 19

Tate & Lyle plc (LON:TATE) Shares Could Be 45% Below Their Intrinsic Value Estimate

Key Insights Tate & Lyle's estimated fair value is UK£12.14 based on 2 Stage Free Cash Flow to Equity Current share...
Analysis Article • Aug 08

Tate & Lyle plc's (LON:TATE) Price Is Right But Growth Is Lacking

Tate & Lyle plc's ( LON:TATE ) price-to-earnings (or "P/E") ratio of 13.9x might make it look like a buy right now...
Analysis Article • Jul 18

Is Tate & Lyle (LON:TATE) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Jun 09

Tate & Lyle's (LON:TATE) Dividend Will Be £0.129

Tate & Lyle plc ( LON:TATE ) has announced that it will pay a dividend of £0.129 per share on the 2nd of August...
Analysis Article • May 26

Tate & Lyle's (LON:TATE) Dividend Will Be £0.129

Tate & Lyle plc ( LON:TATE ) has announced that it will pay a dividend of £0.129 per share on the 2nd of August...
Analysis Article • May 03

Tate & Lyle plc's (LON:TATE) Popularity With Investors Is Under Threat From Overpricing

It's not a stretch to say that Tate & Lyle plc's ( LON:TATE ) price-to-earnings (or "P/E") ratio of 15.1x right now...

Shareholder Returns

TATEGB FoodGB Market
7D0%-5.3%-2.2%
1Y8.3%1.2%14.4%

Return vs Industry: TATE exceeded the UK Food industry which returned 1.2% over the past year.

Return vs Market: TATE underperformed the UK Market which returned 14.4% over the past year.

Price Volatility

Is TATE's price volatile compared to industry and market?
TATE volatility
TATE Average Weekly Movement1.0%
Food Industry Average Movement4.0%
Market Average Movement4.9%
10% most volatile stocks in GB Market10.3%
10% least volatile stocks in GB Market2.6%

Stable Share Price: TATE has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: TATE's weekly volatility has decreased from 8% to 1% over the past year.

About the Company

FoundedEmployeesCEOWebsite
19034,840Nick Hamptonwww.tateandlyle.com

Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverages, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. Its portfolio includes sweeteners, fibres, stabilisers and functional systems, hydrocolloids, and starches, proteins, and functional flours. The company’s products are used in beverages, dairy, soups, sauces and dressings, bakery and snacks, confectionery, household, clinical nutrition, industrial, meat and seafood, and personal care applications.

Tate & Lyle plc Fundamentals Summary

How do Tate & Lyle's earnings and revenue compare to its market cap?
TATE fundamental statistics
Market capUK£2.47b
Earnings (TTM)UK£97.00m
Revenue (TTM)UK£2.01b
25.5x
P/E Ratio
1.2x
P/S Ratio

Is TATE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TATE income statement (TTM)
RevenueUK£2.01b
Cost of RevenueUK£1.09b
Gross ProfitUK£919.00m
Other ExpensesUK£822.00m
EarningsUK£97.00m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

Nov 05, 2026

Earnings per share (EPS)0.22
Gross Margin45.81%
Net Profit Margin4.84%
Debt/Equity Ratio77.5%

How did TATE perform over the long term?

See historical performance and comparison

Dividends

3.5%
Current Dividend Yield
90%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/11 18:00
End of Day Share Price 2026/09/11 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tate & Lyle plc is covered by 25 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alexander SloaneBarclays
Matthew AbrahamBerenberg
Fulvio CazzolBerenberg

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide